Galmarini, Carlos M <br/><br/>
Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.  [electronic resource] 

 -  International journal of pharmaceutics  Aug 2010 
 - 281-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2010.05.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites, Antineoplastic--chemistry<br/>Apoptosis--drug effects<br/>Biological Transport<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Chemistry, Pharmaceutical<br/>Cytarabine--chemistry<br/>Deoxycytidine--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Drug Carriers<br/>Drug Resistance<br/>Drug Resistance, Neoplasm<br/>Gels<br/>Humans<br/>Inhibitory Concentration 50<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Nanoparticles<br/>Nanotechnology<br/>Phosphorylation<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 22--metabolism<br/>Technology, Pharmaceutical--methods<br/>Time Factors<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays<br/>Gemcitabine